Ciriello G, Magnani L, Aitken SJ, Akkari L, Behjati S, Hanahan D, Landau DA, Lopez-Bigas N, Lupianez DG, Marine JC, Martin-Villalba A, Natoli G, Obenauf AC, Oricchio E, Scaffidi P, Sottoriva A, Swarbrick A, Tonon G, Vanharanta S, Zuber J (2024) Cancer evolution: a multifaceted affair
Matthews DR, Paldnius PM, Proot P et al (2019) Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial
Extend Your Learning: Learn More, Save More Whether you are building foundational medical science knowledge, preparing for advanced study, or expanding your understanding of the health care ecosystem, combining courses helps you connect concepts across disciplines while saving on enrollment
What sbir.gov is good for: Cross-agency browsing of currently open topics Looking up past awards (who won what, for how much) Reading the SBIR Policy Directive and SBA guidance Finding agency program office contacts What sbir.gov is not good for: Submitting proposals almost every agency routes you out to a specific portal (DSIP, eRA Commons, NSPIRES, Research.gov, PAMS, Grants.gov) Real-time alerts that match your actual technology focus Eligibility filtering at the company level Tracking topic amendments, Q&A releases, or pre-release period activity Treat sbir.gov as the catalog
Folia Biologica